Webinars » Fully Human Antibody Discovery

Fully Human Antibody Discovery

Antibodies have emerged as significant therapeutics in the market. Accelerating antibody discovery is essential in the fight to develop first-in-class drugs or treatments for new pandemic pathogens, such as coronavirus. Fully human antibody discovery is widely used in early antibody leads discovery. In this webinar, we compare how scientists use innate immune systems to develop phage displayed libraries, Ab humanized animals, and single B cell technology. Recommended strategies for human antibody discovery will also be discussed.

  • Speaker: Dr. Yikai Qiu, Senior Scientist, GenScript ProBio
  • Date: Apr. 3rd, 2020
  • Time: 11:00-11:40AM EST
  • Register

Anti-idiotype antibody generation and applications in antibody drug discovery
Anti-idiotypic Antibody Service DNA Immunization Service Therapeutic Hybridoma Development
  • High specificity & affinity
  • Fast turnaround time: 2-3 months.
  • 100% success rate
  • Solution to problematic antigens, such as membrane proteins
  • Proven track record with 100% success rate
  • Full spectrum of immunization approaches
  • One stop solution
  • High throughput screening